Skip to main content
Clinical Trials/NL-OMON40975
NL-OMON40975CompletedNot Applicable

MYOcardial ischemia detection by circulating bioMARKERs: * the MYOMARKER-study* - MYOMARKER

Meander Medisch Centrum0 sites1,265 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
1,265

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Patients (age >18yr), who are being evaluated in the Meander Medical Center cardiology outpatient clinic with symptoms suggestive for ischemic coronary artery disease, and who will undergo radionuclide myocardial perfusion imaging (rMPI) as indicated by their own cardiologist.

Exclusion Criteria

  • - Age <18 years at time of inclusion
  • - Patients from whom no informed consent is obtained
  • - Incapacitated adults; language barriers or other obstacles for full
  • understanding of the study objectives.

Investigators

Sponsor
Meander Medisch Centrum

Similar Trials